EGFR and non-small cell lung carcinoma: Exon 19 deletion mutations and single-point substitution mutation L858R in exon 21 are considered “classic” mutations that are sensitive to EGFR TKIs and account for 90% of all EGFR mutations in NSCLC [3, 4].